EBV LMP2 peptide FLYALALLL (HLA-A*0201)
IBA Lifescience Kontakt z doradcąSingle peptide synthesized as presented by the MHC class I allele
EBV LMP2 peptide FLYALALLL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from human Epstein-Barr virus (EBV) latent membrane protein 2 (LMP2) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells. The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.
Specifications
- Form: Lyophilized powder
- Peptide Sequence: FLYALALLL
- Possible Application: T cell stimulation
- Purity: > 85%
- Sterility: Sterile
- MHC I Compatibility: HLA-A*0201
